5.1.7

Include a results section; organize the presentation of results around key questions; describe the following (repeat for each key question):

  • Study selection process*

  • List of excluded studies and reasons for their exclusion*

  • Appraisal of individual studies’ quality*

  • Qualitative synthesis

  • Meta-analysis of results, if performed (explain rationale for doing one)*

  • Additional analyses, if done, indicating which were prespecified*

  • Tables and figures

5.1.8

Include a discussion section. Include the following:

  • Summary of the evidence*

  • Strengths and limitations of the systematic review*

  • Conclusions for each key question*

  • Gaps in evidence

  • Future research needs

5.1.9

Include a section describing funding sources* and COI

Standard 5.2 Peer review the draft report

Required elements:

5.2.1

Use a third party to manage the peer review process

5.2.2

Provide a public comment period for the report and publicly report on disposition of comments

Standard 5.3 Publish the final report in a manner that ensures free public access

  

* Indicates items from the PRISMA checklist. (The committee endorses all of the PRISMA checklist items.)

  • Supporting research to improve the communication and use of SRs of CER in clinical decision making;

  • Developing effective coordination and collaboration between U.S. and international partners;

  • Developing a process to ensure that standards for SRs of CER are regularly updated to reflect current best practice; and

  • Using SRs to inform priorities and methods for primary CER.

This recommendation conveys the committee’s view of how best to implement its recommendations to improve the science and sup-



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement